PharmaLundensis AB reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was SEK 1.53 million compared to SEK 0.72635 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.02 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 SEK | +1.69% |
|
-.--% | -20.70% |
05-16 | PharmaLundensis AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-15 | PharmaLundensis AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- PHAL Stock
- News PharmaLundensis AB
- PharmaLundensis AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023